𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson’s disease?

✍ Scribed by Klaus Tatsch

Publisher
Springer
Year
2002
Tongue
English
Weight
87 KB
Volume
29
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PET imaging of the pre-synaptic dopamine
PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP)
✍ Allison Brashear; G. Keith Mulholland; Qi-Huang Zheng; Martin R. Farlow; Eric R. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

## Background: Rapid-onset dystonia-parkinsonism (rdp) is a genetic movement disorder characterized by abrupt onset over hours to days of bradykinesia, postural instability, dysphagia, dysarthria, and severe dystonic spasms with decreased levels of the dopamine metabolite, homovanillic acid (hva),

Altropane, a SPECT or PET imaging probe
Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain
✍ Bertha K. Madras; Lawrence M. Gracz; Michele A. Fahey; David Elmaleh; Peter C. M 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB 👁 2 views

Increasing evidence suggests that the dopamine transporter is situated almost exclusively on dopamine neurons. Accordingly, it is an valuable marker for Parkinson's disease and other pathological states of dopamine neurons. We previously demonstrated that the potent dopamine transport inhibitor [ 12